Cardiovascular Devices Patent Landscape Report 2026 Edition

The global cardiovascular devices market was valued at USD 60.09 Billion in 2025. It is expected to grow at a CAGR of 6.36% during the forecast period of 2026-2035. The market growth is impacted as heart diseases are becoming more common because of unhealthy lifestyles and aging populations. Patents are focused on advanced technologies such as transcatheter aortic valve replacement (TAVR), bioresorbable stents, wearable cardiac monitors, AI driven diagnostics, remote monitoring and telemedicine, among others.

Patent Landscape Report Coverage

The Global Cardiovascular Devices Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for cardiovascular devices include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with cardiovascular devices. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within cardiovascular device technologies.

Key Inclusions:

• Patent Valuation Analysis

An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for cardiovascular device technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with cardiovascular devices.

• Analysis of Patent Applications

A comprehensive summary of several patent applications which were filed across different jurisdictions for cardiovascular devices and their relative value are covered. The analysis will cover the capital in terms of innovation and innovation type.

• Analysis of Granted Patents

Detailed analysis of the granted patents across different jurisdictions for cardiovascular devices and their relative value in the IP are covered in the final report.

What are Cardiovascular Devices?

Cardiovascular devices, which include medical equipment and implants, are used to diagnose, track, and treat disorders of the heart and blood vessels. These consist of cardiac monitoring systems, defibrillators, heart valves, pacemakers, and stents. They lower mortality and improve patient quality of life by managing cardiovascular diseases, restoring normal heart function, and improving blood circulation.

The components of cardiovascular devices include diagnostic and monitoring devices along with surgical devices. In cardiovascular care, surgical devices are instruments used in heart-related procedures to treat conditions like congenital heart defects, valve problems, and coronary artery disease. These include surgical instruments for valve replacement or repair, bypass operations, and vessel anastomosis, as well as heart-lung machines, which momentarily replace the heart and lungs during surgery. For patients undergoing complex heart surgeries, they are essential in increasing surgical outcomes, improving precision, and shortening recovery periods.

Cardiovascular Devices Industry Growth Drivers

Technological Advancements in Cardiac Devices is Expected to Boost the Patent Industry Growth

The advancements in cardiovascular devices like bioresorbable stents, AI-powered diagnostics, and device miniaturization are boosting the incidence of patent applications. For instance, in May 2023, Abbott Laboratories was granted a U.S. patent for its cutting-edge bioresorbable stent that improves long-term vascular healing by having improved structural integrity. These developments fuel market expansion by providing safer and more efficient treatment alternatives.

There is an increase in patent activity which focuses on enhancing the performance of cardiovascular devices. In 2023, 5,860 patents were granted which increased to 6,406 by 2024. Patents covering these technologies are crucial for companies and thus impact the cardiovascular devices patent landscape.

Increasing Prevalence of CVDs is Expected to Propel Cardiovascular Devices Patent Industry

One of the main factors driving the demand for cardiovascular devices is the growing global burden of cardiovascular diseases, which is caused by aging populations, sedentary lifestyles, and rising obesity rates. The adoption of cutting-edge diagnostic and therapeutic solutions has been further accelerated by increased awareness and early diagnosis.

Cardiovascular Devices Patent Segmentation

The report will cover the following sections in detail:

Analysis by Device Type

• Diagnostic & Monitoring Devices
• ECG
• Implantable Cardiac Monitors
• Holter Monitors
• Mobile Cardiac Telemetry
• MRI
• Cardiovascular Ultrasound 2D 3D/4D Doppler
• Cardiac Diagnostic Catheters
• PET Scanner
• Surgical Devices
• Cardiac Resynchronization Therapy (CRT) CRT-Defibrillator CRT-Pacemaker
• Implantable Cardioverter Defibrillators (ICDs) Single Chamber ICDs Dual Chamber ICDs
• Pacemakers Conventional Pacemakers Leadless Pacemakers
• Coronary Stents
• Catheters
• Guidewires
• Cannula
• Valves
• Occlusion Devices

Analysis by Application

• Coronary Artery Disease
• Heart Failure
• Others

Cardiovascular Devices Patent Segmentation Analysis

The breakup based on application includes coronary artery disease, heart failure, and others. Reduced blood flow and an elevated risk of heart attacks result from coronary artery disease (CAD), which is caused by narrowing or blockage of the blood vessels supplying the heart. By reopening blocked arteries and enhancing blood circulation, cardiovascular devices like coronary stents, balloon catheters, and atherectomy devices are frequently used to treat CAD. Medtronic owns a patent for a novel drug-eluting stent that helps CAD patients heal and experience less restenosis. These tools are essential for improving patient outcomes and averting more issues.

Cardiovascular Devices Patent Jurisdiction Analysis

The United States is one of the leading jurisdictions for cardiovascular device patents, having around 197,000+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contributes to the regional patent landscape significantly.

Patent Profile of Key Companies

Among the players with cardiovascular devices patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the cardiovascular devices field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Edwards Lifesciences Corp

It is a well-known American medical technology company that specializes in cardiovascular devices, especially hemodynamic monitoring systems and heart valve therapies. The business is well known for its advancements in surgical heart valves and transcatheter aortic valve replacement (TAVR). Edwards Lifesciences, which has its headquarters in Irvine, California, USA, is dedicated to improving patient care by providing minimally invasive treatments for structural heart diseases and critical care monitoring.

Medtronic Inc.

The company is a world leader in medical technology with a focus on cardiovascular devices like pacemakers, implantable defibrillators, heart valves, and stents. The business is renowned for its groundbreaking advancements in vascular interventions, structural heart therapies, and cardiac rhythm management. Medtronic, a global company with its headquarters in Dublin, Ireland, specializes in enhancing patient outcomes by providing cutting-edge, minimally invasive cardiovascular solutions.

Other companies include Cardiac Pacemakers Inc., Genentech Inc., and Koninklijke Philips NV, among others.

Reasons to Purchase this Report

The cardiovascular devices patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by:

• Competitive Advantage: The landscape reveals the market leaders, potential partners and innovators and makes it understandable which companies have important patents in this field of cardiovascular devices.
• Innovation Insights: The patent analysis reveals new innovations and technologies in cardiovascular devices.
• Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry within the cardiovascular devices patent landscape.
• Risk Assessment: In technology-intensive fields such as cardiovascular devices, risks of IP infringement are common. Analyzing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.

Key Questions Answered in the Cardiovascular Devices Patent Landscape Report

• Who are the key players in the cardiovascular devices patent landscape?
• How is the patent portfolio distributed geographically?
• What are the emerging trends in cardiovascular device patents?
• How has the patent landscape evolved over time?
• What are the strategic insights for market players and investors?
• What is the technological focus of patents in the cardiovascular devices industry?
• How do patent strategies impact competitive advantage?
• What are the implications of patent filings in cardiovascular devices?
• What are the challenges and opportunities in the cardiovascular devices patent landscape?
• What are the regulatory and legal considerations?
• What technological innovations have recently emerged in cardiovascular devices?